Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 12.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.33% |
| Dec 31, 2025 | -1.18% |
| Sep 30, 2025 | 20.28% |
| Jun 30, 2025 | 27.73% |
| Mar 31, 2025 | 143.77% |
| Dec 31, 2024 | 172.80% |
| Sep 30, 2024 | 242.65% |
| Jun 30, 2024 | 8.03% |
| Mar 31, 2024 | -21.28% |
| Dec 31, 2023 | -50.26% |
| Sep 30, 2023 | -235.24% |
| Jun 30, 2023 | 74.67% |
| Mar 31, 2023 | 123.31% |
| Dec 31, 2022 | 267.96% |
| Sep 30, 2022 | 120.23% |
| Jun 30, 2022 | 77.48% |
| Mar 31, 2022 | 72.79% |
| Dec 31, 2021 | -18.61% |
| Sep 30, 2021 | -76.17% |
| Jun 30, 2021 | 24.55% |
| Mar 31, 2021 | -26.50% |
| Dec 31, 2020 | 44.24% |
| Sep 30, 2020 | 217.97% |
| Jun 30, 2020 | -10.77% |
| Mar 31, 2020 | 1,717.68% |
| Dec 31, 2019 | 154.69% |
| Sep 30, 2019 | 273.88% |
| Jun 30, 2019 | 283.73% |
| Mar 31, 2019 | 88.69% |
| Dec 31, 2018 | -169.12% |
| Sep 30, 2018 | -87.64% |
| Jun 30, 2018 | -53.74% |
| Mar 31, 2018 | -14.75% |
| Dec 31, 2017 | -29.41% |
| Sep 30, 2017 | -5.66% |
| Jun 30, 2017 | 15.08% |
| Mar 31, 2017 | 7.78% |
| Dec 31, 2016 | 28.41% |
| Sep 30, 2016 | 11.13% |
| Jun 30, 2016 | -0.23% |
| Mar 31, 2016 | 0.44% |
| Dec 31, 2015 | -66.62% |
| Sep 30, 2015 | 11.19% |
| Jun 30, 2015 | -42.54% |
| Mar 31, 2015 | -41.96% |
| Dec 31, 2014 | -157.63% |
| Sep 30, 2014 | 15.26% |
| Jun 30, 2014 | -1.73% |
| Mar 31, 2014 | -118.49% |
| Dec 31, 2013 | -1,668.83% |
| Sep 30, 2013 | -125.52% |
| Jun 30, 2013 | -987.45% |
| Mar 31, 2013 | -60.15% |
| Dec 31, 2012 | 96.74% |
| Sep 30, 2012 | -132.44% |
| Jun 30, 2012 | 79.26% |
| Mar 31, 2012 | 28.21% |
| Dec 31, 2011 | -222.73% |
| Sep 30, 2011 | -24.76% |